Conducting cancer trials amid the COVID-19 pandemicApril 8, 2020COVID-19 UpdatesSarcoma & GISTRenal Cell CarcinomaPractice ManagementPediatricsPatient & Survivor CareNonmelanoma Skin Cancer
‘Brutal’ plan to restrict palliative radiation during pandemicApril 6, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Advice from the front lines: How cancer centers can cope with COVID-19April 2, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
No staff COVID-19 diagnoses after plan at Chinese cancer centerApril 2, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Perspective from the heartland: Cancer care and research during a public health crisisMarch 26, 2020COVID-19 UpdatesBreast CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Cancer care and COVID-19 in Seattle, the first U.S. epicenterMarch 23, 2020COVID-19 UpdatesCNS/Brain CancerBreast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
How is oncology adapting to COVID-19?March 23, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Disruptions in cancer care in the era of COVID-19March 20, 2020COVID-19 UpdatesPatient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic Cancer
Lymphopenia linked to worse response in RCC, bladder cancer patients on checkpoint inhibitorsMarch 12, 2020Genitourinary CancerRenal Cell Carcinoma
Largest meeting on cancer research canceled: AACRMarch 11, 2020Mixed TopicsLung CancerHead & Neck/Thyroid CancersGynecologic CancerGenitourinary CancerGastroenterologyCNS/Brain Cancer
Bevacizumab/pembrolizumab deemed safe and active in mRCCMarch 7, 2020Renal Cell CarcinomaGenitourinary Cancer
Tumor neoantigenicity metric improves prediction of response to immunotherapyFebruary 22, 2020ImmunotherapyLung CancerRenal Cell CarcinomaMelanoma
Late effects in young cancer survivors underscore importance of high-risk screeningFebruary 21, 2020Mixed TopicsLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersSarcoma & GISTRenal Cell CarcinomaCNS/Brain CancerGenitourinary Cancer
SBRT may boost efficacy of immunotherapy in renal cell carcinomaFebruary 21, 2020Renal Cell CarcinomaGenitourinary Cancer
